Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VARENICLINE vs VEDOLIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VARENICLINE vs VEDOLIZUMAB: Safety Overview

Metric VARENICLINE VEDOLIZUMAB
Total FAERS Reports 20,408 73,857
Deaths Reported 458 3,476
Death Rate 2.2% 4.7%
Hospitalizations 1,754 21,677
Average Patient Age 55.3 yrs 50.0 yrs
% Female Patients 63.9% 56.5%
FDA Approval Date Apr 8, 2025 N/A
Manufacturer Marlex Pharmaceuticals, Inc. Takeda Pharmaceuticals America, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription